Whoop Joins Medicare ACCESS Program; Must Prove Outcomes — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Whoop was accepted into Medicare's 10-year ACCESS pilot, making it one of the first consumer wearable companies available at no cost to traditional Medicare patients 65+ through 54 other participating companies serving chronic-condition management.
- Whoop must demonstrate improved or controlled outcomes on blood pressure, hemoglobin A1C, and LDL cholesterol to receive full payment under the pay-for-performance model, with the company claiming it has already shown a 5 mmHg drop in blood pressure.
- New Whoop CMO Ami Bhatt, who formerly chaired the FDA's digital health advisory committee and served as American College of Cardiology's chief innovation officer, said app simplification is the company's top roadmap priority as it works with the National Council on Aging and AARP to tailor the product.
- Whoop recently raised $575 million from investors including Mayo Clinic and Qatar's sovereign wealth fund, expanding its runway as it pivots from a wellness brand toward clinically validated care.
- The FDA initially warned Whoop that its blood pressure-estimating feature qualified as a medical device rather than a wellness tool, but later closed that letter — months after Whoop began letting users share wearable data directly with their clinicians.
- Bhatt acknowledged the practical bottleneck of wearables in clinical care, recalling patients bringing printed binders of data to 20-minute visits; she described Whoop's response as generating contextualized clinician reports combining continuous data with patients' own journaling and AI coach interactions.
Why it matters: Whoop is switching from selling subscriptions to selling outcomes — Medicare pays only if blood pressure, A1C, or LDL numbers move. With $575 million from Mayo Clinic and Qatar's sovereign wealth fund behind it, the company is essentially betting its consumer-wearable data can produce clinical results in a population 80-plus, a test that, if it works, recasts every fitness band as potential medical infrastructure.
Ask SkimNews
